Marketing Agreement for ACTCellerate™ Cell Lines, Biotime (AMEX: BTX)
December 10th, 2010
No comments
BTX initiated a marketing agreement with Shanghai Genext Medical Technology Co., Ltd. to sell ACTCellerate™ cell lines Read more…
Categories: ACTCellerate™ Cell Lines, AMEX: BTX, Marketing Agreement, Stem Cell Technology
